Sandhya Mudumbi, MD
Hospice and Palliative Medicine · Nashville, TNNPI 1902249089
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,210 of the $1,575 with a category attached, or 76.8%. 21 manufacturers reported payments, led by Lilly USA, LLC at 29.1% of the total. Reporting peaked in 2024 at $461 and has fallen 64.6% since, to $164 in 2025. Among hospice and palliative medicine clinicians in TN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 50 payments — averaging $31.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$459
- AstraZeneca$231
- Regeneron Healthcare Solutions, Inc.$133
- AVEO Pharmaceuticals, Inc.$121
- Merck$106
- Eisai Inc.$93
- plus $432 from 15 others
What the payments were for
- Food & beverage$1,21077%
- Education$36523%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 5 | $459 |
| AstraZeneca(2 entities) | 10 | $231 |
| Regeneron Healthcare Solutions, Inc. | 4 | $133 |
| AVEO Pharmaceuticals, Inc. | 3 | $121 |
| Merck | 4 | $106 |
| Eisai Inc. | 4 | $93 |
| Johnson & Johnson | 3 | $66 |
| Exelixis Inc. | 2 | $54 |
| AbbVie | 2 | $47 |
| Novartis | 2 | $39 |
| Seagen Inc. | 1 | $29 |
| Deciphera Pharmaceuticals Inc. | 1 | $27 |
| EMD Serono, Inc. | 1 | $25 |
| Astellas Pharma US Inc | 1 | $23 |
| Bayer | 1 | $22 |
| Morphosys, US Inc. | 1 | $18 |
| Tersera Therapeutics LLC | 1 | $17 |
| Sumitomo Pharma America, Inc. | 1 | $17 |
| Pharmaessentia USA Corporation | 1 | $17 |
| Puma Biotechnology, Inc. | 1 | $15 |
| Taiho Oncology, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,575 in reported general payments places this provider in the 90th percentile of 34 hospice and palliative medicine providers in Tennessee.
See all hospice and palliative medicine providers in Tennessee →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OxycontinOxycodone Hcl | 30 | $37,198 |
| Xtampza ErOxycodone Myristate | 25 | $16,418 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 108 | $3,532 |
| Oxycodone Hcl | 132 | $2,452 |
| Fentanyl | 37 | $2,148 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 13 | $628 |
| Morphine Sulfate ErMorphine Sulfate | 29 | $586 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 24 | $574 |
| Quetiapine Fumarate | 39 | $560 |
| Duloxetine Hcl | 40 | $470 |
| Gabapentin | 44 | $430 |
| Pregabalin | 27 | $380 |
| Morphine Sulfate | 11 | $344 |
| Olanzapine | 24 | $336 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 15 | $211 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCOlanzapine | $459 | $33624 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 34 hospice and palliative medicine providers in Tennessee.
Other hospice and palliative medicine in Nashville
- Barton SandersNashville$4K
- Christina Macmurdo-FranceNashville$518
- Marc RothmanNashville$72
- Stephen LasherNashville$32
- Stacey TillmanNashville$32
- Michaela IbachNashville$15
- Karen Cole-GeorgeNashville$15
- William JacksonGermantown$93K
- Debra LyonsColumbia$3K
- Melody CunninghamMemphis$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.